Literature Cited

  • 1
    Benz C, Cadman E, Gwin J, Wu T, Amara J, Eisenfeld A, Dannies P. Tamoxifen and 5-fluorouracil in breast cancer: Cytotoxic synergism in vitro. Cancer Res 43: 52985303, 1983.
  • 2
    Benz C, Wiznitzer I, Lee S: Flow cytometric analysis of fluorecent estrogen binding in cancer cell suspensions. In: Morphologic Localization of Putative Steroid Receptors: Techniques. PertschukLP and LeeSH (eds) Vol. 1: CRC Press, Boca Raton FL (in press, 1985).
  • 3
    Best-Belpomme M, Dessen P: Inhibition competitive: Relations linéaires nouvelles et générales. Biochimie 55: 1116, 1973.
  • 4
    Brooks SC, Hansen ER, Saunders DE, Battelli MG, Shafie SM: Effect of growth on the estrogen receptor levels in MCF-7 cells. Cancer Res 44: 37243729, 1984.
  • 5
    Chamness GC, Mercer WD, McGuire WL: Are histochemical methods for estrogen receptors valid? J Histochem Cytochem 28: 792798, 1980.
  • 6
    Clark JH, Markaverich B, Upchurch S, Eriksson H, Hardin JW, Peck EJ: Heterogeneity of estrogen binding site: Relationship to estrogen receptors and estrogen responses. Recent Progr Horm Res 36: 89134, 1980.
  • 7
    Curtin CT, Pertschuk LP, Mitchell V: Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Acta Cytol 26: 841846, 1982.
  • 8
    Dandliker WB, Brawn RJ, Hsu ML, Brawn PN, Levin J, Meyers CV, Kolb VM: Investigation of hormone-receptor interactions by means of fluorescence labeling. Cancer Res 38: 42144224, 1978.
  • 9
    Danguy A, Leclerq G, Pattyn G, Devleeschouwer N, Pasteels JL, Hsueon JC: Cyochemical analysis of human breast cancer with fluorescent sex-steroid conjugates: Comparison with biochemical assessment of oestrogen receptors. Anticancer Res 1: 361366, 1981.
  • 10
    Fisher B, Gunduz N, Saffer EA: Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding following primary tumor removal radiation, cyclophosphamide, or tamoexifen. Cancer Res 43: 52445247, 1983.
  • 11
    Hanna W, Ryder DE, Mobbs BG: Cellular localization of estrogen binding sites in human breast cancer. Am J. Clin Pathol 77: 391395, 1982.
  • 12
    Joyce BG, Nicholson RI, Morton MS, Griffiths K: Studies with steroid-fluorescein conjugates on oestrogen target tissues. Eur J Cancer Clin Oncol 18: 11471155, 1982.
  • 13
    Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaicik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659670, 1979.
  • 14
    Kute TE, Linville C, Barrows G, Cytofluorometric analysis for estrogen receptors using fluorescent estrogen probes Cytometry 4: 132140, 1983.
  • 15
    Lee SH: Cytochemical study of estrogen receptor in human mammary carcinoma. Am J Clin Pathol 70: 197203, 1978.
  • 16
    Lee SH: Cancer cell estrogen receptor of human mammary carcinoma. Cancer 44: 112, 1979.
  • 17
    Lee SH: Cellular estrogen and progesterone receptors in mammary carcinoma. Am J Clin Pathol 73: 323329, 1980.
  • 18
    Lee SH: Uterine epithelial and eosinophil estrogen receptors in rats during the estrous cycle. Histochemistry 74: 443452, 1982.
  • 19
    Lee SH: The histochemistry of estrogen receptors. Histochemistry 71: 491500, 1981.
  • 20
    Lee SH: Estrogen-primed immature rat uterus–a tissue control for histochemical estrogen receptor assay. Am J Clin Pathol 79: 484486, 1983.
  • 21
    Lee SH: Validity of a histochemical estrogen receptor assay supported by the observation of a cellular response to steroid manipulation. J Histochem Cytochem 32: 305310, 1984.
  • 22
    McCarty KS Jr, Reintgen MD, Seigler HF, McCarty KS Sr: Cytochemistry of sex steroid receptors: A critique. Breast Cancer Res Treat 1: 315325, 1982.
  • 23
    Meijer CJLM, Van Marle J, Persijn JP, Van Niewenhuizen W, Baak JPA, Boon ME, Lindeman J: Estrogen receptors in human breast cancer II. Correlation between the histochemical method and biochemical assay. Virchows Arch (Cell Pathol) 40: 2737, 1982.
  • 24
    Oxenhandler RW, McCune R, Subtelney A, Truelove C, Tyrer HW: Flow cytometric determination of estrogen receptors in intact cells Cancer Res 44: 25162523, 1984.
  • 25
    Pertschuk LP, Gaetjens E, Carter AC, Brigati DJ, Kim DS, Fealey TE: An improved histochemical method for detection of estrogen receptors in mammary cancer. Am J Clin Pathol 71: 504508, 1979.
  • 26
    Pertschuk LP, Tobin EH, Carter AC, Eisenberg KB, Leo VC, Gaetjens E, Bloom ND: Immunohistologic and histochemical methods for detection of steroid binding in breast cancer: A reappraisal. Breast Cancer Res Treat 1: 297314, 1981.
  • 27
    Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci USA 51: 660672, 1959.
  • 28
    Segal IH: Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Stady-State Enzyme Systems. John Wiley & Sons, New York, 1975, pp 161226.
  • 29
    Shafie S, Brooks S: Effect of prolactin on growth and the estrogen receptor level of breast cancer cells (MCF-7). Cancer Res 37: 792799, 1977.
  • 30
    Soule HD, Vasquez J, Lang A, Albert S, Brennan MJ: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 14091416, 1973.
  • 31
    Taylor CM, Blanchard B, Zava DR: A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture. J Steroid Biochem 20: 10831088, 1984.
  • 32
    Van Marle J, Lindeman J, Ariens AT, Labruyere W, van Weeren-Kramer J: Estrogen receptors in human breast cancer. I. Specificity of the histochemical localization of estrogen receptors using an estrogen-albumin FITC complex. Virchows Arch (Cell Pathol) 40: 1725, 1982.
  • 33
    Yao X, Meng X, Chen P, Mei Z: Histochemical estrogen receptor assay for selecting stage III breast cancers for combined chemohormonal therapy. Lab Invest 48: 9596, 1983.